🚨 Major Update in Alzheimer's Diagnosis 🚨 The Alzheimer's Association has released new criteria for diagnosing Alzheimer's disease, sparking debate in the medical community. Key points: New criteria incorporate advanced lab work Potential for earlier diagnosis and treatment Concerns raised about over-diagnosis and pharmaceutical influence This update is likely to increase Alzheimer's diagnoses significantly. While early detection can open new treatment avenues, some worry about unnecessary labeling. Adding to the controversy: The approval board includes pharmaceutical industry representatives FDA's approval of Eli Lilly's early Alzheimer's treatment, donanemab, followed shortly after What are your thoughts on this development? How might it impact patients, healthcare providers, and the pharmaceutical industry? This link to a CNN Health article has more details: https://lnkd.in/eDfsSkcP #Alzheimers #Healthcare #MedicalEthics #Neuroscience
Yes. Many other possiblililities need to be ruled out. Blood work and MRI required as well
Managing Attorney of Rothkoff Law Group, an Elder Care Law Firm
16hThe Alz. Assoc has its own agenda which not all experts agree with. This article is an example. https://www.nytimes.com/2024/07/07/opinion/alzheimers-missed-opportunities.html?smid=nytcore-ios-share&referringSource=articleShare